Telemedicine-supported Management for Acute Ischemic Stroke
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Telemedicine-Supported Management.
- Who it may be relevant to
- Registry conditions: Acute Ischemic Stroke. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Telemedicine-supported Management of Acute Ischemic Stroke in the Basic-level Hospitals
Overview
Telemedicine-supported stroke care can provide standardized guidance to hospitals and regions with limited medical resources, thereby improving treatment outcomes for stroke patients in these areas. While this approach has been widely adopted in many developed countries, its efficacy in guiding basic-level hospitals to manage acute ischemic stroke requires further investigation through large-scale, high-quality studies. This study focused on patients with acute ischemic stroke who sought treatment at basic-level hospitals, aiming to investigate the efficacy and safety of treating acute ischemic stroke with telemedicine-supported management. Hospitals assigned to the experimental group received remote consultation guidance, quality control and professional training from expert teams at leading stroke centers, China National Center for Neurological Disorders. Hospitals in the control group did not receive telemedicine-supported management.
Interventions
- Other Telemedicine-Supported Management
Receive round-the-clock 7×24h remote consultation guidance from expert teams at leading stroke centers, covering patient triage and initial assessment, thrombolysis decision-making, and treatment guidance. Undergo quality control for standardized workflow implementation, and professional training.
Primary outcome measures
- Proportion of patients with mRS scores of 0-1 [Time frame: 90 days]
Secondary outcome measures (4)
- Intravenous thrombolysis rate [Time frame: 4.5 hours]
- mRS score [Time frame: 90 days]
- Door-to-(thrombolysis)needle-time [Time frame: 4.5 hours]
- Rate of endovascular therapy receipt among eligible patients [Time frame: 24 hours]
Eligibility criteria
Inclusion criteria
- Hospital Inclusion Criteria:
- Basic-level hospitals in China (Definition: Hospitals classified as secondary-level (Grade II) or below under China's Hospital Grading Management Standards, or hospitals located in counties/county-level cities).
- Equipped with an emergency department and neurology ward capable of admitting stroke patients.
- Equipped with CT and/or MRI capable of diagnosing AIS.
- Equipped with intravenous thrombolytic drugs for acute ischemic stroke.
- Patient Inclusion Criteria:
- Age ≥ 18 years.
- Diagnosed with acute ischemic stroke.
- CT/MRI confirms absence of intracerebral hemorrhage.
- Onset of stroke symptoms ≤ 4.5 hours.
- pre-stroke mRS score ≤1.
- Informed consent obtained from patient or their legal representative.
Exclusion criteria
- Hospital Exclusion Criteria:
- Admitting fewer than 10 patients with acute ischemic stroke per month.
- Currently participating in other clinical trials that may interfere with this trial.
- Patient Exclusion Criteria:
- Presence of contraindications for intravenous thrombolysis according to AHA/ASA guidelines
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
China · 1 center
- Xuanwu Hospital — Beijing
Identifiers
NCT: NCT07302971 · TOGETHER